Humira Biosimilars Market

HUMIRA® (Adalimumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive / Terminated / Withdrawn Biosimilars, Industry / Non-Industry Partnerships

  • Lowest Price Guaranteed From USD 949

  • Companies Covered
    0

  • Pages
    85

  • View Count
    11668

Table Of Contents

Excel Deliverable

1. Dashboard
A. Overall Summary
B. Approved & Launched Biosimilars
C. Investigational & Research Use Biosimilars
D. Inactive / Terminated / Withdrawn Biosimilars
E. Commercialization Partners
F. Partnerships & Collaborations
G. Individual Biosimilar Details

2. Data Table 1: Summary

3. Data Table 2: Approved and Launched Products

4. Data Table 3: Investigational and Research Use Products

5. Data Table 4: Commercialization Partners

6. Data Table 5: Partnerships

7. Appendix I: Pivot Tables

PowerPoint Deliverable

1. Context

2. Executive Summary

3. Overview of Biosimilars

4. About the Reference Product

5. Contemporary Pipeline Analysis
5.1. Approved / Launched Products
5.2. Investigational and Research Use Products
5.3. Inactive / Terminated / Withdrawn Products
5.4. Commercialization Partners

6. Analysis of Partnerships

7. Company Profiles
7.1. Company A, (California, USA)
7.2. Company B, (Guangzhou, China)
7.3. Company C, (Ahmedabad, India)
7.4. Company D, (Incheon, South Korea)
7.5. Company E, (Tehran, Iran)
7.6. Company F, (Pune, India)
7.7. Company G, (Hessen, Germany)
7.8. Company H, (Tokyo, Japan)
7.9. Company I, (Hyderabad, India)
7.10. Company J, (Suzhou, China)
7.11. Company K, (Seoul, South Korea)
7.12. Company L, (New York, USA)
7.13. Company M, (Navi Mumbai, India)
7.14. Company N, (Incheon, South Korea)
7.15. Company O, (Holzkirchen, Germany)
7.16. Company P, (Shanghai, China)
7.17. Company Q, (Ahmedabad, India)

8. Appendices

Source 1: news.abbvie.com/news/abbvie-reports-full-year-and-fourth-quarter-2018-financial-results.htm
Source 2: www.pharmaceutical-technology.com/comment/abbvies-successful-hard-ball-with-humira/#:~:text=While%20Humira's%20primary%20patent%20was,or%20pursue%20their%20own%20settlements.

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com